SCHEMBL4481218

SCHEMBL4481218

BrC1OCCO1.[MgH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1632482 0.96
SCHEMBL27294991 0.80
SCHEMBL27290476 0.80
SCHEMBL29210428 0.63
SCHEMBL1612976 0.61
SCHEMBL27926356 0.58
SCHEMBL3069575 0.58
SCHEMBL9500691 0.58
SCHEMBL9921412 0.56
Propylene Oxide SCHEMBL27305299 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7595337-B2 2-Carbonyl-3-phenyl-2,3,3a,4-tetrahydrochromeno[4,3-c]pyrazole derivatives such as 2-acetyl-8-fluoro-3-phenyl-2,3,3a,4-tetrahydrochromeno[4,3-c]pyrazole and 3S,3aS)-2-acetyl-8-chloro-7-methyl-3-phenyl-2,3,3a,4-tetrahydrochromeno[4,3-c]pyrazole that are useful for treating cancer MERCK & CO. INC. (US) 2009-09-29 US disclosed
US-20080182843-A1 Mitotic Kinesin Inhibitors MERCK SHARP & DOHME CORP. 2008-07-31 US disclosed
EP-1851213-A2 MITOTIC KINESIN INHIBITORS Merck & Co., Inc. (US) 2007-11-07 EP disclosed
WO-2006086358-A2 MITOTIC KINESIN INHIBITORS MERCK & CO., INC. (US) 2006-08-17 WO disclosed